PRKAA1 and cancer: Moreover, metformin (100 μM-10 mM for cells and 300–500 mg/kg for mice models) also amplifies its therapeutic effects and enhances cancer patient survival beneficial in an AMPK-dependent way when combined with radiotherapy or chemotherapy [80, 81].